Chemical Approaches to Understanding Reversible Lysine Modifications

理解可逆赖氨酸修饰的化学方法

基本信息

  • 批准号:
    10621611
  • 负责人:
  • 金额:
    $ 44.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-04-01 至 2028-03-31
  • 项目状态:
    未结题

项目摘要

Abstract This is an R35 NIGMS application that is meant to succeed R37GM62437 and concerns the development and application of chemical approaches to enhance our understanding of histone post-translational modifications (PTMs) on Lys residues and the enzymes that attach and remove them (“writers” and “erasers”). Our lab has a record of technical innovation in the chemical biology of histone modifications including bivalent analog design and protein semisynthesis. Our bivalent compound approaches have led to the generation of potent and selective inhibitors of p300 and CBP (p300/CBP) acetyltransferases and the LSD1-HDAC1-CoREST (LHC) demethylase/ deacetylase gene silencing complex. Our latest-generation compounds, A485 for p300/CBP and corin for LHC have become very useful and popular pharmacological probes for analyzing these histone- modifying enzymes in mechanistic and preclinical therapeutic experiments. Our protein semisynthetic methods including expressed protein ligation, engineered sortase-catalyzed histone production, and Cys modification to introduce acyl-Lys mimics have proven to be efficient approaches to furnish site-specifically modified proteins. In recent years we have shown how particular histone modifications influence nucleosome stability and susceptibility to eraser enzymes including deacetylase, demethylase, and deubiquitinase isoforms. Notably, we have discovered a new case of histone mark (PTM) crosstalk—an apparent gatekeeper function for histone H3 acetylation at Lys14 in blocking LSD1 demethylation of H3 methyl-Lys4. In the next phase of our research program, we will develop and apply new chemical methods to more broadly understand the biology of histone mark crosstalk using protein semisynthesis, gene editing, structural approaches, and “cut and paste” mass spec proteomics. We will explore structural and functional features of enzymatic nucleosome interactions in the context of LSD1, PRC1, SAGA, HDAC1, and Sirt6 complexes in part by incorporating chemical warheads into designer nucleosomes. In addition, we will apply a newly engineered version of sortase to isolate histone H3 tails from cellular chromatin to quantitatively readout patterns of PTMs in different cell types and in response to pharmacological agents by employing tandem mass tag mass spectrometry. Upon completion of this research effort, our findings will broaden the knowledge of how histone Lys modifications are “written” and “erased” and how specific PTM patterns regulate gene expression and cell fate. Moreover, these studies should pave the way for new therapeutic strategies to combat epigenetic dysregulation in various diseases. This research program will also enable the training of the next generation of biochemical investigators interested in protein science and guided by a commitment to diversity and inclusion.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PHILIP A COLE其他文献

PHILIP A COLE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PHILIP A COLE', 18)}}的其他基金

FASEB SRC on Reversible Acetylation in Health and Disease
FASEB SRC 关于健康和疾病中的可逆乙酰化
  • 批准号:
    9750429
  • 财政年份:
    2019
  • 资助金额:
    $ 44.75万
  • 项目类别:
Biochemistry of the lysine beta-hydroxybutyrylation pathway
赖氨酸β-羟基丁酰化途径的生物化学
  • 批准号:
    10210387
  • 财政年份:
    2018
  • 资助金额:
    $ 44.75万
  • 项目类别:
Mechanistic Studies of EGFR/ErbB Receptor Tyrosine Kinases
EGFR/ErbB 受体酪氨酸激酶的机制研究
  • 批准号:
    8606747
  • 财政年份:
    2012
  • 资助金额:
    $ 44.75万
  • 项目类别:
Mechanistic Studies of EGFR/ErbB Receptor Tyrosine Kinases
EGFR/ErbB 受体酪氨酸激酶的机制研究
  • 批准号:
    8795729
  • 财政年份:
    2012
  • 资助金额:
    $ 44.75万
  • 项目类别:
Mechanistic Studies of EGFR/ErbB Receptor Tyrosine Kinases
EGFR/ErbB 受体酪氨酸激酶的机制研究
  • 批准号:
    8436210
  • 财政年份:
    2012
  • 资助金额:
    $ 44.75万
  • 项目类别:
Mechanistic Studies of EGFR/ErbB Receptor Tyrosine Kinases
EGFR/ErbB 受体酪氨酸激酶的机制研究
  • 批准号:
    8310660
  • 财政年份:
    2012
  • 资助金额:
    $ 44.75万
  • 项目类别:
Development and Application of Ghrelin O-acyltransferase Inhibitors
Ghrelin O-酰基转移酶抑制剂的开发及应用
  • 批准号:
    8215389
  • 财政年份:
    2011
  • 资助金额:
    $ 44.75万
  • 项目类别:
Histone Modification Mechanisms and Inhibition
组蛋白修饰机制和抑制
  • 批准号:
    7937324
  • 财政年份:
    2009
  • 资助金额:
    $ 44.75万
  • 项目类别:
TCP5: ACTIVE SITE LABELING REAGENT FOR ACETYLTRANSFERASES
TCP5:乙酰转移酶活性位点标记试剂
  • 批准号:
    7724689
  • 财政年份:
    2008
  • 资助金额:
    $ 44.75万
  • 项目类别:
TCP5: ACTIVE SITE LABELING REAGENT FOR ACETYLTRANSFERASES
TCP5:乙酰转移酶活性位点标记试剂
  • 批准号:
    7622843
  • 财政年份:
    2007
  • 资助金额:
    $ 44.75万
  • 项目类别:

相似海外基金

Dissecting out differential molecular phenotypes across Lysine(K) AcetylTransferase mutations in mouse development
剖析小鼠发育过程中赖氨酸(K)乙酰转移酶突变的差异分子表型
  • 批准号:
    10727966
  • 财政年份:
    2023
  • 资助金额:
    $ 44.75万
  • 项目类别:
Targeting lysine acetyltransferase MOF/KAT8 in lung cancer
靶向赖氨酸乙酰转移酶 MOF/KAT8 在肺癌中的作用
  • 批准号:
    10601761
  • 财政年份:
    2023
  • 资助金额:
    $ 44.75万
  • 项目类别:
Defining the cell-type specific role of histone acetyltransferase KAT2a in nucleus accumbens D1 medium spiny neurons as a driver of cocaine use disorder
定义组蛋白乙酰转移酶 KAT2a 在伏隔核 D1 中型多棘神经元中作为可卡因使用障碍驱动因素的细胞类型特异性作用
  • 批准号:
    10679238
  • 财政年份:
    2023
  • 资助金额:
    $ 44.75万
  • 项目类别:
Roles of lysine acetyltransferase 6 complexes in cerebral development and neurodevelopmental disorders
赖氨酸乙酰转移酶 6 复合物在大脑发育和神经发育障碍中的作用
  • 批准号:
    479754
  • 财政年份:
    2023
  • 资助金额:
    $ 44.75万
  • 项目类别:
    Operating Grants
Examination of the Histone Acetyltransferase CBP in the Remodelling of Thermogenic Adipose Tissues
组蛋白乙酰转移酶 CBP 在生热脂肪组织重塑中的检测
  • 批准号:
    486467
  • 财政年份:
    2022
  • 资助金额:
    $ 44.75万
  • 项目类别:
    Studentship Programs
Development of p300/CBP histone acetyltransferase inhibitors for oncogene-driven cancers
开发用于癌基因驱动癌症的 p300/CBP 组蛋白乙酰转移酶抑制剂
  • 批准号:
    10344246
  • 财政年份:
    2022
  • 资助金额:
    $ 44.75万
  • 项目类别:
Nuclear activity of carnitine acetyltransferase
肉毒碱乙酰转移酶的核活性
  • 批准号:
    RGPIN-2018-06089
  • 财政年份:
    2022
  • 资助金额:
    $ 44.75万
  • 项目类别:
    Discovery Grants Program - Individual
Development of p300/CBP histone acetyltransferase inhibitors for oncogene-driven cancers
开发用于癌基因驱动癌症的 p300/CBP 组蛋白乙酰转移酶抑制剂
  • 批准号:
    10627744
  • 财政年份:
    2022
  • 资助金额:
    $ 44.75万
  • 项目类别:
Characterizing the role of the NuA3 histone acetyltransferase complex during transcription
表征 NuA3 组蛋白乙酰转移酶复合物在转录过程中的作用
  • 批准号:
    557615-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 44.75万
  • 项目类别:
    Postdoctoral Fellowships
Structural and functional studies of histone acetyltransferase complexes
组蛋白乙酰转移酶复合物的结构和功能研究
  • 批准号:
    RGPIN-2018-03951
  • 财政年份:
    2022
  • 资助金额:
    $ 44.75万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了